Lords Mark Industries promoter to reinvest ₹87 crore sale proceeds in medical devices
- Promoter Sachidanand Hariram Upadhyay sold 1,03,56,983 shares on September 18, 2026
- Net proceeds from the transaction amounted to ₹87.39 crore
- Majority of funds proposed for reinvestment into medical device unit expansion
- Promoter shareholding reduced to 75.11% from 77.54%

*this image is generated using AI for illustrative purposes only.
Lords Mark Industries Limited promoter Sachidanand Hariram Upadhyay has proposed reinvesting the majority of funds from a recent equity stake sale towards expanding the company's medical device unit. The proposal follows the offloading of 1,03,56,983 shares on September 18, 2026, which generated net proceeds of ₹87.39 crore.
The disclosure was filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transaction was executed through the open market on the BSE. Following the sale, Upadhyay's shareholding decreased to 75.11% from the previous 77.54%.
Transaction details
The disposal represented 2.43% of the company's total paid-up share capital. The total equity share capital remains unchanged at ₹426,62,22,170, consisting of 42,66,22,217 equity shares of ₹10 each. There were no changes to the encumbrance status or voting rights other than those attached to the equity shares sold.
| Metric | Before Sale | After Sale | Change |
|---|---|---|---|
| Shares held | 33,07,96,229 | 32,04,39,246 | -1,03,56,983 |
| % Holding | 77.54% | 75.11% | -2.43% |
| Net Proceeds | N/A | N/A | ₹87.39 crore |
Reinvestment plan
The promoter confirmed that the funds credited to his bank account will be reinvested through viable and acceptable means. The primary objective is the expansion of the company's medical device operations. This strategic move signals continued commitment to the core business despite the reduction in personal holding percentage.
What the Numbers Show
The retention of a 75.11% majority stake ensures continued control over the entity. The specific allocation of ₹87.39 crore towards medical device expansion highlights a pivot in capital deployment strategy. Unlike previous disposals which might have served liquidity needs, this reinvestment proposal directly links the sale proceeds to operational growth in a high-value segment.
Historical Stock Returns for Lords Mark Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.01% | -0.08% | -4.51% | 0.0% | 0.0% | 0.0% |
What specific product lines or technologies within the medical device unit will receive priority funding from the ₹87.39 crore reinvestment?
How does this capital injection align with Lords Mark Industries' projected revenue growth targets for the medical device segment over the next fiscal year?
Will the expansion of the medical device operations require additional external debt financing or further equity dilution beyond the promoter's reinvestment?




























